[The clinical significance of tissue polypeptide antigen (TPA) in the patients with gynecologic tumor]. 1984

M Inoue, and Y Inoue, and K Hiramatsu, and Y Tanaka, and M Yamasaki, and G Ueda, and J Minagawa, and M Ozaki, and T Yanagida, and H Nishino

In order to estimate the clinical significance of tissue polypeptide antigen (TPA), TPA was measured by radioimmunoassay in sera from patients with various gynecological tumors. They were 40 uterine myomas, 94 cervical cancers, 21 endometrial cancers, 3 vulval cancers, 51 benign ovarian tumors and 78 malignant ovarian tumors including 18 low potential malignant tumors (LPM). The mean TPA values in patients with benign as well as malignant tumors were significantly higher than that of 97 healthy volunteers (68 +/- 17 U/l; Upper limit; 107 U/l). Among the cervical cancer patients, serum TPA level and positive ratio became higher as the disease progressed. In the advanced cases, the mean serum TPA value and positive ratio were 149 +/- 64 U/l and 75%, respectively. The mean TPA value in the endometrial cancer patients was significantly higher than that of myoma patients. Among the patients with ovarian tumor, serum TPA was elevated in 14% of benign cases, 28% of LPM cases, 47% of stage I cases and 82% of the advanced cases. Serum TPA values varied directly with the stage and malignancy of disease. The present study revealed that TPA is a useful markers in the diagnosis of gynecological tumors, especially for ovarian cancers.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D002294 Carcinoma, Squamous Cell A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed) Carcinoma, Epidermoid,Carcinoma, Planocellular,Carcinoma, Squamous,Squamous Cell Carcinoma,Carcinomas, Epidermoid,Carcinomas, Planocellular,Carcinomas, Squamous,Carcinomas, Squamous Cell,Epidermoid Carcinoma,Epidermoid Carcinomas,Planocellular Carcinoma,Planocellular Carcinomas,Squamous Carcinoma,Squamous Carcinomas,Squamous Cell Carcinomas
D003884 Dermoid Cyst A tumor consisting of displaced ectodermal structures along the lines of embryonic fusion, the wall being formed of epithelium-lined connective tissue, including skin appendages, and containing keratin, sebum, and hair. (Stedman, 25th ed) Dermoid,Cyst, Dermoid,Cysts, Dermoid,Dermoid Cysts,Dermoids
D005260 Female Females
D005833 Genital Neoplasms, Female Tumor or cancer of the female reproductive tract (GENITALIA, FEMALE). Gynecologic Neoplasms,Female Genital Neoplasms,Neoplasms, Female Genital,Neoplasms, Gynecologic,Female Genital Neoplasm,Genital Neoplasm, Female,Gynecologic Neoplasm,Neoplasm, Female Genital,Neoplasm, Gynecologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Inoue, and Y Inoue, and K Hiramatsu, and Y Tanaka, and M Yamasaki, and G Ueda, and J Minagawa, and M Ozaki, and T Yanagida, and H Nishino
October 1985, Nihon Gan Chiryo Gakkai shi,
M Inoue, and Y Inoue, and K Hiramatsu, and Y Tanaka, and M Yamasaki, and G Ueda, and J Minagawa, and M Ozaki, and T Yanagida, and H Nishino
April 1987, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
M Inoue, and Y Inoue, and K Hiramatsu, and Y Tanaka, and M Yamasaki, and G Ueda, and J Minagawa, and M Ozaki, and T Yanagida, and H Nishino
October 1984, Nihon Sanka Fujinka Gakkai zasshi,
M Inoue, and Y Inoue, and K Hiramatsu, and Y Tanaka, and M Yamasaki, and G Ueda, and J Minagawa, and M Ozaki, and T Yanagida, and H Nishino
December 1981, British journal of urology,
M Inoue, and Y Inoue, and K Hiramatsu, and Y Tanaka, and M Yamasaki, and G Ueda, and J Minagawa, and M Ozaki, and T Yanagida, and H Nishino
January 1989, Zentralblatt fur Gynakologie,
M Inoue, and Y Inoue, and K Hiramatsu, and Y Tanaka, and M Yamasaki, and G Ueda, and J Minagawa, and M Ozaki, and T Yanagida, and H Nishino
December 1999, Nihon rinsho. Japanese journal of clinical medicine,
M Inoue, and Y Inoue, and K Hiramatsu, and Y Tanaka, and M Yamasaki, and G Ueda, and J Minagawa, and M Ozaki, and T Yanagida, and H Nishino
August 2005, Nihon rinsho. Japanese journal of clinical medicine,
M Inoue, and Y Inoue, and K Hiramatsu, and Y Tanaka, and M Yamasaki, and G Ueda, and J Minagawa, and M Ozaki, and T Yanagida, and H Nishino
March 1984, Gan no rinsho. Japan journal of cancer clinics,
M Inoue, and Y Inoue, and K Hiramatsu, and Y Tanaka, and M Yamasaki, and G Ueda, and J Minagawa, and M Ozaki, and T Yanagida, and H Nishino
March 1990, Annals of the Academy of Medicine, Singapore,
M Inoue, and Y Inoue, and K Hiramatsu, and Y Tanaka, and M Yamasaki, and G Ueda, and J Minagawa, and M Ozaki, and T Yanagida, and H Nishino
May 1986, Nihon Gan Chiryo Gakkai shi,
Copied contents to your clipboard!